Erythropoietin (EPO) Drugs Market Report

China Erythropoietin (EPO) Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：225
  • REPORT CODE：GMM1806584
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow.

    Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these diseases may cause anemia. To curb rising incidence of anemia, demand for erythropoietin drugs is expected to increase over the coming years.

    This report elaborates on the current development of the Erythropoietin (EPO) Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Johnson & Johnson

    • Kyowa Hakko Kirin

    • Roche

    • Amgen

    • LG Life Sciences

    • Emcure

    • 3SBio

    • Biocon

    By Type:

    • Others

    • Darbepoetin-alfa

    • Epoetin-alfa

    • Epoetin-beta

    By Application:

    • Other

    • Kidney Disorders

    • Anemia

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Erythropoietin (EPO) Drugs Market Overview 2018-2029

    • 1.1 China Erythropoietin (EPO) Drugs Industry Development Overview

    • 1.2 China Erythropoietin (EPO) Drugs Industry Development History

    • 1.3 China Erythropoietin (EPO) Drugs Industry Market Size (2018-2029)

    • 1.4 China Erythropoietin (EPO) Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Darbepoetin-alfa (2018-2029)

      • 1.4.3 China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Epoetin-alfa (2018-2029)

      • 1.4.4 China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Epoetin-beta (2018-2029)

    • 1.5 China Erythropoietin (EPO) Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Erythropoietin (EPO) Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China Erythropoietin (EPO) Drugs Sales Volume, Sales Value and Growth Rate of Kidney Disorders (2018-2029)

      • 1.5.3 China Erythropoietin (EPO) Drugs Sales Volume, Sales Value and Growth Rate of Anemia (2018-2029)

    • 1.6 China Erythropoietin (EPO) Drugs Market Analysis by Region

      • 1.6.1 North China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Erythropoietin (EPO) Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Erythropoietin (EPO) Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Erythropoietin (EPO) Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Erythropoietin (EPO) Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Erythropoietin (EPO) Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Erythropoietin (EPO) Drugs Industry Development

    Chapter 3 Erythropoietin (EPO) DrugsIndustry Chain Analysis

    • 3.1 Erythropoietin (EPO) Drugs Industry Chain

    • 3.2 Erythropoietin (EPO) Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Erythropoietin (EPO) Drugs Market

    • 3.3 Erythropoietin (EPO) Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Erythropoietin (EPO) Drugs Market

    Chapter 4 China Erythropoietin (EPO) Drugs Market, by Type

    • 4.1 China Erythropoietin (EPO) Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Erythropoietin (EPO) Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Erythropoietin (EPO) Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Others

      • 4.5.2 China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Darbepoetin-alfa

      • 4.5.3 China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Epoetin-alfa

      • 4.5.4 China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Epoetin-beta

    Chapter 5 China Erythropoietin (EPO) Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Erythropoietin (EPO) Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Erythropoietin (EPO) Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Erythropoietin (EPO) Drugs Market Size and Growth Rate of Other

      • 5.5.2 China Erythropoietin (EPO) Drugs Market Size and Growth Rate of Kidney Disorders

      • 5.5.3 China Erythropoietin (EPO) Drugs Market Size and Growth Rate of Anemia

    Chapter 6 China Erythropoietin (EPO) Drugs Market, by Region

    • 6.1 China Erythropoietin (EPO) Drugs Production Volume and Production Value, by Region

    • 6.2 China Erythropoietin (EPO) Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Erythropoietin (EPO) Drugs Market Analysis

    • 7.1 North China Erythropoietin (EPO) Drugs Market, by Type

    • 7.2 North China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 8 Central China Erythropoietin (EPO) Drugs Market Analysis

    • 8.1 Central China Erythropoietin (EPO) Drugs Market, by Type

    • 8.2 Central China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 9 South China Erythropoietin (EPO) Drugs Market Analysis

    • 9.1 South China Erythropoietin (EPO) Drugs Market, by Type

    • 9.2 South China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 10 East China Erythropoietin (EPO) Drugs Market Analysis

    • 10.1 East China Erythropoietin (EPO) Drugs Market, by Type

    • 10.2 East China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 11 Northeast China Erythropoietin (EPO) Drugs Market Analysis

    • 11.1 Northeast China Erythropoietin (EPO) Drugs Market, by Type

    • 11.2 Northeast China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 12 Southwest China Erythropoietin (EPO) Drugs Market Analysis

    • 12.1 Southwest China Erythropoietin (EPO) Drugs Market, by Type

    • 12.2 Southwest China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 13 Northwest China Erythropoietin (EPO) Drugs Market Analysis

    • 13.1 Northwest China Erythropoietin (EPO) Drugs Market, by Type

    • 13.2 Northwest China Erythropoietin (EPO) Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Johnson & Johnson

        • 14.1.1 Johnson & Johnson Company Profile

        • 14.1.2 Johnson & Johnson Erythropoietin (EPO) Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Kyowa Hakko Kirin

        • 14.2.1 Kyowa Hakko Kirin Company Profile

        • 14.2.2 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Roche

        • 14.3.1 Roche Company Profile

        • 14.3.2 Roche Erythropoietin (EPO) Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Amgen

        • 14.4.1 Amgen Company Profile

        • 14.4.2 Amgen Erythropoietin (EPO) Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 LG Life Sciences

        • 14.5.1 LG Life Sciences Company Profile

        • 14.5.2 LG Life Sciences Erythropoietin (EPO) Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Emcure

        • 14.6.1 Emcure Company Profile

        • 14.6.2 Emcure Erythropoietin (EPO) Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 3SBio

        • 14.7.1 3SBio Company Profile

        • 14.7.2 3SBio Erythropoietin (EPO) Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Biocon

        • 14.8.1 Biocon Company Profile

        • 14.8.2 Biocon Erythropoietin (EPO) Drugs Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Erythropoietin (EPO) Drugs Industry Research Conclusions

    • 15.2 Erythropoietin (EPO) Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Erythropoietin (EPO) Drugs Industry Market Size (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Darbepoetin-alfa (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Epoetin-alfa (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Production Volume, Production Value and Growth Rate of Epoetin-beta (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Sales Volume, Sales Value and Growth Rate of Kidney Disorders (2018-2029)

    • Figure China Erythropoietin (EPO) Drugs Sales Volume, Sales Value and Growth Rate of Anemia (2018-2029)

    • Figure North China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Erythropoietin (EPO) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Erythropoietin (EPO) Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Erythropoietin (EPO) Drugs Market Share by Type in 2018

    • Figure China Erythropoietin (EPO) Drugs Market Share by Type in 2023

    • Figure China Erythropoietin (EPO) Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Darbepoetin-alfa (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Epoetin-alfa (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Production Volume and Growth Rate of Epoetin-beta (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Market Share by Application in 2018

    • Figure China Erythropoietin (EPO) Drugs Market Share by Application in 2023

    • Figure China Erythropoietin (EPO) Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Erythropoietin (EPO) Drugs Market Size and Growth Rate of Other (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Market Size and Growth Rate of Kidney Disorders (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Market Size and Growth Rate of Anemia (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Production Volume by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Production Volume Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Production Volume Share by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Production Value by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Production Value Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Production Value Share by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Sales Volume by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Sales Volume Share by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Sales Value by Region (2018-2023)

    • Table China Erythropoietin (EPO) Drugs Sales Value Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Drugs Sales Value Share by Region (2018-2023)

    • Table North China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table North China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table North China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table North China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table Central China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table Central China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table South China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table South China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table South China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table East China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table East China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table East China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Erythropoietin (EPO) Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Erythropoietin (EPO) Drugs Sales Volume Share by Application (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table Kyowa Hakko Kirin Company Profile

    • Table Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table LG Life Sciences Company Profile

    • Table LG Life Sciences Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table Emcure Company Profile

    • Table Emcure Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table 3SBio Company Profile

    • Table 3SBio Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Erythropoietin (EPO) Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US